Mercy Hospital in Chicago has developed a successful hybrid cath lab program where various specialties work together for ...
Structural Heart
This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).
November 20, 2012 — Medtronic Inc. announced the first treatment of a U.S. patient in its global, multicenter ...
November 16, 2012 — The U.S. Court of Appeals for the Federal Circuit affirmed an April 2010 federal jury decision that ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
The PC Trial data presented at TCT 2012 looked at transcather PFO closure vs. medical therapy in preventing cryptogenic ...
November 8, 2012 — A clinical trial indicates that using an investigational medical device to close a PFO, or “hole in ...
Hospitals constantly try to predict what the future holds when planning new facilities and equipment purchases that will ...
Positive results from the RESPECT Trial of transcatheter patent foramen ovale (PFO) closure vs. standard medical therapy ...
November 5, 2012 — Medtronic Inc. announced new findings from the Medtronic CoreValve ADVANCE Study for one-year ...
November 5, 2012 — Edwards Lifesciences Corporation announced three-year results of a pivotal clinical study of ...
November 5, 2012 — Direct Flow Medical Inc. announced that its DISCOVER CE mark trial met its primary mortality endpoint ...
November 2, 2012 – A clinical trial that compared catheter-based PFO closure using an investigational device found that ...
November 1, 2012 — Medtronic Inc. announced promising data from the Engager European Pivotal Trial for the ...
October 30, 2012 — W. L. Gore & Associates responded to initial results reported in St. Jude Medical Inc.’s RESPECT ...
October 22, 2012 — W. L. Gore & Associates announced that the U.S. Food and Drug Administration (FDA) has approved the ...
October 19, 2012 — The 24th Transcatheter Cardiovascular Therapeutics (TCT) conference, sponsored by the Cardiovascular ...
November 20, 2012